220 related articles for article (PubMed ID: 28153791)
1. HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis.
Ryu HW; Shin DH; Lee DH; Choi J; Han G; Lee KY; Kwon SH
Cancer Lett; 2017 Apr; 391():162-171. PubMed ID: 28153791
[TBL] [Abstract][Full Text] [Related]
2. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
3. Drugging the HDAC6-HSP90 interplay in malignant cells.
Krämer OH; Mahboobi S; Sellmer A
Trends Pharmacol Sci; 2014 Oct; 35(10):501-9. PubMed ID: 25234862
[TBL] [Abstract][Full Text] [Related]
4. A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status.
Ryu HW; Shin DH; Lee DH; Won HR; Kwon SH
Carcinogenesis; 2018 Jan; 39(1):72-83. PubMed ID: 29106445
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.
Rao R; Fiskus W; Yang Y; Lee P; Joshi R; Fernandez P; Mandawat A; Atadja P; Bradner JE; Bhalla K
Blood; 2008 Sep; 112(5):1886-93. PubMed ID: 18591380
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.
Kovacs JJ; Murphy PJ; Gaillard S; Zhao X; Wu JT; Nicchitta CV; Yoshida M; Toft DO; Pratt WB; Yao TP
Mol Cell; 2005 May; 18(5):601-7. PubMed ID: 15916966
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics.
Jochems J; Teegarden SL; Chen Y; Boulden J; Challis C; Ben-Dor GA; Kim SF; Berton O
Biol Psychiatry; 2015 Feb; 77(4):345-55. PubMed ID: 25442004
[TBL] [Abstract][Full Text] [Related]
9. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer.
Seidel C; Schnekenburger M; Mazumder A; Teiten MH; Kirsch G; Dicato M; Diederich M
Biochem Pharmacol; 2016 Jan; 99():31-52. PubMed ID: 26549368
[TBL] [Abstract][Full Text] [Related]
10. Aceroside VIII is a new natural selective HDAC6 inhibitor that synergistically enhances the anticancer activity of HDAC inhibitor in HT29 cells.
Ryu HW; Lee DH; Shin DH; Kim SH; Kwon SH
Planta Med; 2015 Feb; 81(3):222-7. PubMed ID: 25590368
[TBL] [Abstract][Full Text] [Related]
11. Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer.
Yu S; Cai X; Wu C; Liu Y; Zhang J; Gong X; Wang X; Wu X; Zhu T; Mo L; Gu J; Yu Z; Chen J; Thiery JP; Chai R; Chen L
Int J Biol Sci; 2017; 13(4):505-517. PubMed ID: 28529458
[TBL] [Abstract][Full Text] [Related]
12. A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells.
Won HR; Ryu HW; Shin DH; Yeon SK; Lee DH; Kwon SH
Mol Carcinog; 2018 Oct; 57(10):1383-1395. PubMed ID: 29917295
[TBL] [Abstract][Full Text] [Related]
13. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90.
Meng Q; Chen X; Sun L; Zhao C; Sui G; Cai L
Mol Cell Biochem; 2011 Feb; 348(1-2):165-71. PubMed ID: 21082217
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6.
Qu X; Du J; Zhang C; Fu W; Xi H; Zou J; Hou J
PLoS One; 2012; 7(2):e32215. PubMed ID: 22384180
[TBL] [Abstract][Full Text] [Related]
16. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.
Yang Y; Rao R; Shen J; Tang Y; Fiskus W; Nechtman J; Atadja P; Bhalla K
Cancer Res; 2008 Jun; 68(12):4833-42. PubMed ID: 18559531
[TBL] [Abstract][Full Text] [Related]
17. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
Lu CY; Chang YC; Hua CH; Chuang C; Huang SH; Kung SH; Hour MJ; Lin CW
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468311
[TBL] [Abstract][Full Text] [Related]
18. HDAC6 deficiency induces apoptosis in mesenchymal stem cells through p53 K120 acetylation.
Park SY; Phorl S; Jung S; Sovannarith K; Lee SI; Noh S; Han M; Naskar R; Kim JY; Choi YJ; Lee JY
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):51-56. PubMed ID: 29054408
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.
Joshi AD; Barabutis N; Birmpas C; Dimitropoulou C; Thangjam G; Cherian-Shaw M; Dennison J; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1410-9. PubMed ID: 26498249
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]